RecruitingNot ApplicableNCT04905160

Care Coordination to Assess Improvement in Outcomes in Hospital Readmissions

Care cOordination Using Mobile Technology to Enhance Patient Empowerment in Acute Comorbidities to aSSess Improvement in Outcomes in Hospital readmissioNs

Sponsor

Aventyn, Inc.

Enrollment

1,000 participants

Start Date

Feb 18, 2021

Study Type

INTERVENTIONAL

Conditions

Heart Failure ADHF Acute MI

Summary

Heart failure is a syndrome that is defined by distinctive clinical, hemodynamic, and neurohormonal findings. HF represents a final common pathway for many different cardiovascular diseases, including coronary disease, hypertension, Valvular disease, and many primary heart muscle diseases. Clinically, HF patients experience dyspnea, fatigue and diminished exercise tolerance, reflecting elevated left and/or right ventricular filling pressures and decreased cardiac output.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether a care coordination program — using nurses and technology to closely follow patients after hospital discharge — reduces readmissions for people hospitalized with acute heart failure or a heart attack, and in a separate phase, for older adults with COVID-19. **You may be eligible if...** - You are 18 years or older - You are hospitalized with a primary diagnosis of acute heart failure or a heart attack - For the COVID-19 phase: you are 50 or older with a positive COVID-19 test and at least one additional risk factor **You may NOT be eligible if...** - You are considered unreliable for follow-up by the investigator - You are unable to comply with study requirements - You are a patient where the study conditions are not met within 48 hours of a positive COVID test (for the COVID phase) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERCOMPASSION Digital Biomarker

Vitals data collected by the Vitalbeat workbench for biomarker based algorithm variables will be used to drive intervention based on PAP systolic and diastolic pressures.

Locations(1)

Multiple Locations

Phoenix, Arizona, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04905160

Related Trials

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

NCT06424288653 locations

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

NCT06935370638 locations

Impact of Optimized Pacing Strategies on Clinical and Hemodynamic Outcomes in Heart Failure Patients With Pacemaker

NCT075631531 location

A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)

NCT06991257135 locations

The Salt Study for Heart Failure

NCT075605921 location